Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford plans to keep the information collected about you (and Boehringer Ingelheim will safely keep a copy of the de-identified database) for at least 25 years after the end of the study, and perhaps longer if required by the law or other research needs to undertake the EASi-KIDNEYTM trial. This is so the results of the trial can be checked by healthcare regulators, such as the Medicines and Healthcare products Regulatory Agency (MHRA), U.S. Food and Drug Administration (U.S. FDA) or European Medicines Agency, if needed.